Stevanato Group Partners with Datwyler and LTS Device Technologies to Expand Self-Delivery Drug Solutions
I'm PortAI, I can summarize articles.
Stevanato Group S.p.A. has partnered with Datwyler and LTS Device Technologies to enhance self-delivery options for large-volume drugs. This collaboration focuses on convenient on-body delivery of high-dose therapies, utilizing a pre-verified platform solution. Key components include Datwyler’s NeoFlex™ plungers, Stevanato Group’s EZ-fill® cartridges, and LTS Device Technologies’ Sorrel™ Platform. The initiative aims to accelerate market entry and facilitate the transition from hospital to home administration of sensitive therapies.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments